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Abstract
Background: Hepatic angiomyolipomas are a rare, benign group of mesenchymal tumors in the liver. Hepatic
angiomyolipoma is sometimes misdiagnosed as hepatocellular carcinoma, and there is the possibility of a
malignant transformation. Hence, the accurate diagnosis of this disorder is necessary.
Case presentation: A 64-year-old Japanese man was observed to have a space-occupying lesion of 15-mm
diameter in the liver during a follow-up examination for a previously resected cecal carcinoma. He underwent
lateral segmentectomy of the liver with a provisional diagnosis of hepatic metastatic recurrence of the carcinoma
based on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging
and diffusion-weighted imaging.
Conclusions: We have explored the combination of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-
enhanced magnetic resonance imaging and histological examination to confirm our diagnosis of hepatic
angiomyolipoma comprising an intimate mixture of numerous abnormal blood vessels, adipocytes, and epithelioid
spindle cells of various sizes. Immunohistochemical examination revealed characteristic pathological findings
associated with positive qualitative immunoreactions for human melanoma black 45 and desmin. Electron
microscopic findings revealed the presence of melanosomes in the epithelioid cells. Diffusion-weighted imaging
provides a more accurate diagnostic image with the characteristic macroscopic appearance of hepatic
angiomyolipoma. Through immunohistochemistry and electron microscopy, we also show that this benign tumor
comprises tissue elements.
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Background
Angiomyolipoma (AML) is a rare, benign mesenchy-
mal neoplasm most often arising in the kidney. Hep-
atic angiomyolipoma (HAML) is a rare, benign
mesenchymal liver tumor first described by Ishak in
1976 [1]; it belongs to a group of perivascular epitheli-
oid cell (PEC) tumors called PEComas [2]. HAML
may be derived from PECs [3], which are cells with
multiple differentiation potentials that are capable
of differentiating into vascular smooth muscle and
epithelial cells and expressing the melanoma cell
marker human melanoma black (HMB)-45 [4].
Recently, HAML lesions identified by focusing on
gadolinium ethoxybenzyl diethylenetriamine pentaacetic
acid-enhanced magnetic resonance imaging (Gd-EOB-
DTPA MRI), immunohistochemistry, and both clinical
and pathological characteristics of the tumors were re-
ported [5]. However, to the best of our knowledge, there
is no case report to date on the combination of
Gd-EOB-DTPA MRI, immunohistochemistry, and elec-
tron microscopy. In this report, we aim to further
characterize HAML, in particular that of the epithelioid,
the phenotypic smooth muscle spindle type, and adipo-
cytic cells.
* Correspondence: yokomori@insti.kitasato-u.ac.jp
4Department of Internal Medicine, Kitasato University Medical Center,
Saitama, Japan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kubo et al. Journal of Medical Case Reports  (2017) 11:76 
DOI 10.1186/s13256-017-1235-1
Case presentation
A 64-year-old Japanese man with no evidence of tuber-
ous sclerosis was discovered to have a space-occupying
lesion in the liver during a follow-up examination for
cecal cancer. After ileocecal cancer surgery, no signs of
metastasis were detected on imaging examinations, and
tumor markers were not detected. No infectious dis-
eases, such as schistosomiasis, were detected, and the
patient did not use oral hormonal agents. Physical exam-
ination of the patient’s abdomen revealed normal active
bowel sounds, no tenderness or rebound tenderness of
the epigastrium, and no hepatomegaly or splenomegaly.
Results of tests for antibodies against hepatitis B surface
antigen and hepatitis C virus were negative. Tumor
marker levels, such as α-fetoprotein, protein induced by
vitamin K absence or antagonist II, carcinoembryonic
antigen, and carbohydrate antigen 19-9, were within the
normal ranges. Abdominal ultrasonography revealed a
25-mm low-density tumor with a high-density area in
segment 2 (S2) of the liver. Gd-EOB-DTPA MRI also
showed a slight T2 hyperintensity (Fig. 1a) and T1
hypointensity 22 × 12-mm tumor (Fig. 1b) in S2 of the
liver. Heterogeneous high signal intensity was markedly
seen in the arterial phase of the dynamic Gd-EOB-
DTPA MRI (Fig. 1c), with multiple central filiform ves-
sels and capsule enhancement. The signal intensity was
relatively reduced in the portal venous phase (PVP)
(Fig. 1d), but it was slightly higher than that in the
surrounding liver parenchyma with an enhanced vas-
cular signal visible in the lesion (Fig. 1e). The signal
intensity of the tumor was lower at the parenchymal
phase than at the surrounding liver parenchyma
(Fig. 1e). A lack of Gd-EOB-DTPA uptake was noted
in the hepatobiliary phase (HBP) at 20 minutes postin-
jection (Fig. 1f ).
With a clinical diagnosis of hepatocellular carcinoma
(HCC) and hepatic adenoma, a partial hepatectomy of
S2 was performed. The resected specimen showed a
tumor of 25 mm in diameter. The cut surface of the
resected liver showed a relatively firm, whitish-gray nod-
ule, which was well circumscribed from the surrounding
hepatic parenchyma. Some very small, yellowish areas
were embedded at the periphery. No distinct necrotic
areas were noted (Fig. 2a). A hematoxylin and eosin-
stained section showed growth of eosinophilic ovoid
cells and spindle cells with focal admixture of mature
adipocytes (Fig. 2b). A number of vascular channels
were intermingled. Irregular dilation and thickening of
the vascular wall were occasionally observed. Immuno-
histochemical analysis revealed eosinophilic ovoid cells
positive for HMB-45 (Fig. 2c) and Melan-A. In contrast,
spindle cells were positive for desmin (Fig. 2d). Vigorous
staining of CD34 exhibited a dense vascular network
of the tumor (Fig. 2e). Moreover, the tumor cells were
focally positive for S100 (Fig. 2f ). In some cases, useful
information has been obtained by transmission electron
microscopy after tissue collection. We investigated the
reembedding of formalin-fixed and paraffin-embedded
specimens with epon resin. HAMLs, each composed of
an intimate mixture of numerous abnormal blood ves-
sels with fat, spindle, and/or epithelioid cells of various
sizes, were found on electron microscopic examination.
Capillary endothelial cells with Weibel-Palade bodies
showed abnormal thickening of the subendothelial
spaces containing collagen fibrils in a homogeneous
matrix, fibroblast-like cells, and nonspecific vesicular
structures. These findings suggest secondary vascular
damage; the thickened vessels may not be a primary, in-
tegral part of HAML (Fig. 3a and b). Smooth muscle
cells showed abundant accumulation of glycogen and
myofilaments with a few dense granules (Fig. 3c and d).
Myofilaments were typically dispersed at the periphery
of the cell along the cytoplasmic membranes (Fig. 3c
and d). Some epithelioid cells contained concentric
membranous endoplasmic reticulum, numerous mito-
chondria, and cytoplasmic glycogen granules (Fig. 3e
and f). In adipocytic cells, the cytoplasm was occupied
by homogeneous osmophilic lipid vacuoles that were not
membrane-bound. Occasional cells were multivacuolar
(Fig. 3g and h). Cytoplasmic myelin figures and melano-
somes were present in epithelioid cells (Fig. 3i). We di-
agnosed type I mixed type HAML. The patient was alive
with no tumor recurrence or metastasis at the 1-year
follow-up.
Discussion
Most of the patients with HAML have no symptoms
and their lesions are detected incidentally during rou-
tine medical examination [6]. The typical appearance
of HAML is that of a smoothly contoured, heteroge-
neous, high-echo lesion. Our patient had a history of
cecal cancer surgery, and HAML was detected inci-
dentally during a routine follow-up imaging examin-
ation. Gd-EOB-MRI also confirmed a large tumor in
the caudate lobe and numerous smaller nodules in
the right lobe of the liver. A combination of Gd-
EOB-MRI and diffusion-weighted imaging (DWI) pro-
vided even higher diagnostic sensitivity. Last, the
characteristic macroscopic appearance and histopath-
ology provided a definitive diagnosis.
HAML comprises three tissue elements: blood vessels,
epithelia or spindle-shaped smooth muscle cells, and
mature adipose tissue. Immunohistochemical staining
showed absence of hepatocytes, but smooth muscle cells
were strongly positive for a melanocytic cell-specific
monoclonal antibody. The final histopathological diag-
nosis (HMB-45-positive) is consistent with HAML.
Moreover, formalin-fixed tissue sections examined under
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an electron microscope showed moderate amounts of
stacked, rough endoplasmic reticulum; mitochondria;
lysosomes; and oval, cytoplasmic, melanosome-like,
electron-dense granules.
According to the differential diagnosis, we first investi-
gated HAML using Gd-EOB-DTPA MRI, immunohisto-
chemical analyses, and electron microscopy. Type I
hybrid-type lesions were enhanced in the arterial phase
but were followed by rapid washout in the PVP and de-
layed phases.
Because the radiological features of HAML depend on
the relative proportion of adipose cells in the tumor,
HAML was not readily distinguishable from HCC [5–8].
Liver biopsy was helpful in the preoperative diagnosis of
AML [9]. In this case, it was difficult to perform liver bi-
opsy because the tumor was located just below the liver
capsule. In the present case, we suspected HCC and he-
patocellular adenoma.
The imaging characteristics of HAML correlated with
its histological components, and detection of fat content
Fig. 1 Magnetic resonance imaging (MRI) findings. a T2-weighted image with fat saturation showing a heterogeneous hyperintense mass in
segment 2 of the right hepatic lobe. b T1-weighted image showing the lesion with a homogeneous low signal intensity. c–f Gadolinium ethoxybenzyl
diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging findings. c Marked heterogeneous high signal intensity in the arterial phase of
the dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging scan. d The signal intensity is relatively
reduced in the portal venous phase, but slightly higher than in the surrounding liver parenchyma, with an enhanced vascular signal visible in the lesion.
e The signal intensity of the tumor is lower at the parenchymal phase than in the surrounding liver parenchyma. f A lack of gadolinium ethoxybenzyl
diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging uptake is noted in the hepatobiliary phase at 40 minutes
postinjection. Arrowheads denote tumor lesion in segment 2 of liver
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was typical of HAML. MRI is more sensitive than com-
puted tomography in detecting fatty tissue, which appears
hypointense on fat saturation pulses or chemical shift im-
aging. However, it is occasionally difficult to differentiate
between HAML and other hepatic tumors that contain
fatty tissue, such as fatty metamorphosis of HCC, hepato-
cellular adenoma with fat content, lipoma, and liposar-
coma [8, 9].
The MRI findings reported by Sakamoto were of a
low-signal-intensity mass with some tiny, high-signal-
intensity foci on T1-weighted images. The tiny, high-
signal-intensity foci were thought to be due to abundant
adipose tissues, as indicated by the results of immuno-
histochemical examination [10].
Moreover, according to a recent study in which re-
searchers compared Gd-EOB-MRI features of lipid-poor
HAMLs and HCCs, both lesions showed similar dy-
namic enhancement patterns during the arterial phase,
followed by hypointensity on PVP or transitional phase
(late dynamic phase) [11]. However, considering that
HAMLs are devoid of hepatocytes, whereas HCCs do
contain hepatocytes with various degrees of malignant
change, homogeneous hypointensity of the mass on HBP
imaging and a lower value of relative signal intensity on
HBP compared with that of the spleen may suggest
hepatic AML rather than HCC [11]. HAML can be di-
vided into four groups based on the tissue components
(thick-walled vessels, adipose tissue epithelioid smooth
Fig. 2 Pathological findings. a Macroscopic findings. The excised section of the tumor shows only a solid component, without a cystic component or
apparent capsule. b Microscopic findings. A tumor without fibrous capsule with interlacing bands of uniform spindle cells, of which elongated nuclei
are arranged in a palisading pattern. c, d Immunohistochemical findings The epithelioid spindle cells are strongly positively stained for (c) human
melanoma black 45 and (d) desmin. e CD34 underlined the rich demonstrate abundant mature vascular structures. f The tumor cells are
focally positive for S100
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Fig. 3 (See legend on next page.)
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muscle cell, and four subtypes: [1] hybrid: the most
common type, which contains similar proportions of
each tissue element within the tumor; [2] myoma:
smooth muscle tissue, which is the dominant element;
[3] lipoma: adipose tissue, which is the dominant elem-
ent; and [4] hemangioma: dominated by the vascular
element) [12]. In our patient, T2-weighted MRI se-
quences showed slight hyperintensity, whereas T1-
weighted MRI sequences showed a hypointense tumor.
Heterogeneous high signal intensity was particularly ob-
served in the arterial phase of the dynamic Gd-EOB-
DTPA MRI sequence with multiple central filiform ves-
sels and capsular enhancement. The signal intensity was
relatively reduced in the PVP. A lack of Gd-EOB-DTPA
uptake was noted in the HBP at 20 minutes postinjec-
tion; in our patient, the tumor was thought to be of the
hybrid mixed type.
Considering the developmental site of HAML, in
our patient, because immunohistochemical analyses
and electron microscopy revealed all three compo-
nents of an AML (vascular cells, immature smooth
muscle cells, and fat cells) and because three differen-
tiated epithelioid cells contained a so-called secondary
hit mutation, they were believed to have derived from
a common progenitor cell [13]. Earlier reports de-
scribed ultrastructural findings of HAML cells [14,
15], but no report of the relevant literature has ex-
plained the structure of myelin figures. In our patient,
electron microscopy revealed the presence of cytoplas-
mic myelin figures and melanosomes in the epithelioid
cells. These cells were derived from undifferentiated
cells of neural cast [13]. Generally, S100 staining was
negative in HAML. Nevertheless, some cases of
immunoexpression of S100 by HAML have been
reported [16]. Although they were not immunohisto-
chemically detected on the neural cell, electron mi-
croscopy revealed myelin figures in the cytoplasm or
as inclusions in mitochondria and autophagic vacu-
oles, where they might represent artifacts of lipid fix-
ation [17]. Two hypotheses have been proposed to
explain the histogenesis of HAML. One is that
HAMLs derive from undifferentiated cells of the
neural crest that can express dual smooth muscle and
melanocytic phenotypes. The second is that these
tumors are of myoblastic and, more specifically,
smooth muscle origin, but that they are molecularly
altered. They coexpress melanogenesis and melanocy-
tic markers [13]. Recently, telocytes have been shown
to give rise, in several organs, to a spectrum of lesions
that variably express at least some of the cell differen-
tiation markers [18].
HAML is generally managed as a benign tumor in
clinical settings; however, since 2000, several reports
have revealed its potential for malignant transformation
with evidence of recurrence [19, 20]. Maklouf et al.
showed that CD117 is positive in all cases of benign
renal AML and HAML [21]. In our patient, the tissue
stained positive for CD117 (data not shown). Therefore,
a consensus on the optimal treatment approach for
HAML is yet to be established. Actually, HAML com-
prises a rare, benign group of mesenchymal tumors in
the liver. Moreover, its cause remains unclear. We also
elucidated five electron microscopic features of HAML
in our patient. Vascular and smooth muscle components
were monoclonal, whereas three types of differentiated
epithelioid cells of fat tissue components were poly-
clonal. This finding suggests that the tumor cells derived
from HAMLs were a type of primitive mesenchymal cell
with multidifferentiation potential. These cells might dif-
ferentiate into vascular smooth muscle cells and adipo-
cytes [13].
According to the future plan, no signs of tumor recur-
rence or metastasis were observed during the follow-up
period. Therefore, HAML should not be considered as
an entirely benign tumor; at least, there is a possibility of
its malignant transformation. We will continue with
periodic imaging examinations for our patient.
Conclusions
We have explored the combination of Gd-EOB-DTPA
MRI and DWI, which provides a more accurate diagnos-
tic picture with the characteristic macroscopic appear-
ance of HAML. Moreover, HAML is sometimes
misdiagnosed as HCC. This may lead to its malignant
transformation. Hence, its accurate diagnosis is neces-
sary. Through immunohistochemistry and electron mi-
croscopy, we have also shown that this benign tumor
comprises tissue elements.
(See figure on previous page.)
Fig. 3 Electron microscopic findings. a, b Capillary endothelial cells show abnormal thickening of the subendothelial spaces containing collagen
fibrils in a homogeneous matrix, fibroblast-like cells, and nonspecific vesicular structures. White arrowheads indicate Weibel-Palade bodies. c, d
Smooth muscle cells with abundant accumulation of glycogen and myofilaments, as well as a few dense granules. Myofilaments are dispersed at
the periphery of the cell along the cytoplasmic membranes. White arrows indicate myofilaments. e, f Epithelioid cells contained concentric
membranous endoplasmic reticulum, numerous mitochondria, and cytoplasmic glycogen granules. Double arrowheads indicate mitochondria. g,
h Adipocytic cells occupied by homogeneous osmophilic lipid vacuoles that are not membrane-bound. Black arrowheads denote lipid vacuoles.
i Epithelioid cells contain myelin figures. Melanosomes were present in the epithelioid cells. Black arrows denote melanosome. Star denotes
myelin features in a, c, e and g (low magnification). b, d, f, h, i High-magnification views
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